A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer

被引:157
作者
Bonnomet, A. [1 ,4 ]
Syne, L. [1 ]
Brysse, A. [1 ]
Feyereisen, E. [1 ]
Thompson, E. W. [2 ,3 ]
Noel, A. [1 ]
Foidart, J-M [1 ]
Birembaut, P. [4 ]
Polette, M. [4 ]
Gilles, C. [1 ]
机构
[1] Univ Liege, GIGA Canc, Lab Tumor & Dev Biol, B-4000 Liege, Belgium
[2] St Vincents Inst, Melbourne, Vic, Australia
[3] Univ Melbourne, St Vincents Hosp, Dept Surg, Melbourne, Vic, Australia
[4] INSERM, Unite U903, Lab Pol Bouin, Reims, France
关键词
EMT; circulating tumor cells; metastases; vimentin; MDA-MB-468; GROWTH-FACTOR RECEPTOR-2; GENE-EXPRESSION; STEM-CELL; CARCINOMA CELLS; E-CADHERIN; BASAL; SNAIL; PHENOTYPE; INVASION; SUBTYPE;
D O I
10.1038/onc.2011.540
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epithelial-to-mesenchymal transition (EMT) processes endow epithelial cells with enhanced migratory/invasive properties and are therefore likely to contribute to tumor invasion and metastatic spread. Because of the difficulty in following EMT processes in human tumors, we have developed and characterized an animal model with transplantable human breast tumor cells (MDA-MB-468) uniquely showing spontaneous EMT events to occur. Using vimentin as a marker of EMT, heterogeneity was revealed in the primary MDA-MB-468 xenografts with vimentin-negative and vimentin-positive areas, as also observed on clinical human invasive breast tumor specimens. Reverse transcriptase-PCR after microdissection of these populations from the xenografts revealed EMT traits in the vimentin-positive zones characterized by enhanced 'mesenchymal gene' expression (Snail, Slug and fibroblast-specific protein-1) and diminished expression of epithelial molecules (E-cadherin, ZO-3 and JAM-A). Circulating tumor cells (CTCs) were detected in the blood as soon as 8 days after s.c. injection, and lung metastases developed in all animals injected as examined by in vivo imaging analyses and histology. High levels of vimentin RNA were detected in CTCs by reverse transcriptase-quantitative PCR as well as, to a lesser extent, Snail and Slug RNA. Von Willebrand Factor/vimentin double immunostainings further showed that tumor cells in vascular tumoral emboli all expressed vimentin. Tumoral emboli in the lungs also expressed vimentin whereas macrometastases displayed heterogenous vimentin expression, as seen in the primary xenografts. In conclusion, our data uniquely demonstrate in an in vivo context that EMT occurs in the primary tumors, and associates with an enhanced ability to intravasate and generate CTCs. They further suggest that mesenchymal-to-epithelial phenomena occur in secondary organs, facilitating the metastatic growth. Oncogene (2012) 31, 3741-3753; doi:10.1038/onc.2011.540; published online 28 November 2011
引用
收藏
页码:3741 / 3753
页数:13
相关论文
共 40 条
[1]   Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients [J].
Aktas, Bahriye ;
Tewes, Mitra ;
Fehm, Tanja ;
Hauch, Siegfried ;
Kimmig, Rainer ;
Kasimir-Bauer, Sabine .
BREAST CANCER RESEARCH, 2009, 11 (04)
[2]   Epithelial-to-Mesenchymal Transitions and Circulating Tumor Cells [J].
Bonnomet, Arnaud ;
Brysse, Anne ;
Tachsidis, Anthony ;
Waltham, Mark ;
Thompson, Erik W. ;
Polette, Myriam ;
Gilles, Christine .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2010, 15 (02) :261-273
[3]   Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: Role of fibroblast growth factor receptor-2 [J].
Chaffer, Christine L. ;
Brennan, Janelle P. ;
Slavin, John L. ;
Blick, Tony ;
Thompson, Erik W. ;
Williams, Elizabeth D. .
CANCER RESEARCH, 2006, 66 (23) :11271-11278
[4]   Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition [J].
Chao, Yvonne L. ;
Shepard, Christopher R. ;
Wells, Alan .
MOLECULAR CANCER, 2010, 9
[5]   Intestinal adenomagenesis involves core molecular signatures of the epithelial-mesenchymal transition [J].
Chen, Xiaodi ;
Halberg, Richard B. ;
Burch, Ryan P. ;
Dove, William F. .
JOURNAL OF MOLECULAR HISTOLOGY, 2008, 39 (03) :283-294
[6]   The role of epithelial-mesenchymal transition in cancer pathology [J].
Guarino, Marcello ;
Rubino, Barbara ;
Ballabio, Gianmario .
PATHOLOGY, 2007, 39 (03) :305-318
[7]   Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics [J].
Hennessy, Bryan T. ;
Gonzalez-Angulo, Ana-Maria ;
Stemke-Hale, Katherine ;
Gilcrease, Michael Z. ;
Krishnamurthy, Savitri ;
Lee, Ju-Seog ;
Fridlyand, Jane ;
Sahin, Aysegul ;
Agarwal, Roshan ;
Joy, Corwin ;
Liu, Wenbin ;
Stivers, David ;
Baggerly, Keith ;
Carey, Mark ;
Lluch, Ana ;
Monteagudo, Carlos ;
He, Xiaping ;
Weigman, Victor ;
Fan, Cheng ;
Palazzo, Juan ;
Hortobagyi, Gabriel N. ;
Nolden, Laura K. ;
Wang, Nicholas J. ;
Valero, Vicente ;
Gray, Joe W. ;
Perou, Charles M. ;
Mills, Gordon B. .
CANCER RESEARCH, 2009, 69 (10) :4116-4124
[8]   Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors [J].
Herschkowitz, Jason I. ;
Simin, Karl ;
Weigman, Victor J. ;
Mikaelian, Igor ;
Usary, Jerry ;
Hu, Zhiyuan ;
Rasmussen, Karen E. ;
Jones, Laundette P. ;
Assefnia, Shahin ;
Chandrasekharan, Subhashini ;
Backlund, Michael G. ;
Yin, Yuzhi ;
Khramtsov, Andrey I. ;
Bastein, Roy ;
Quackenbush, John ;
Glazer, Robert I. ;
Brown, Powel H. ;
Green, Jeffrey E. ;
Kopelovich, Levy ;
Furth, Priscilla A. ;
Palazzo, Juan P. ;
Olopade, Olufunmilayo I. ;
Bernard, Philip S. ;
Churchill, Gary A. ;
Van Dyke, Terry ;
Perou, Charles M. .
GENOME BIOLOGY, 2007, 8 (05)
[9]   Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients [J].
Kallergi, Galatea ;
Papadaki, Maria A. ;
Politaki, Eleni ;
Mavroudis, Dimitris ;
Georgoulias, Vassilis ;
Agelaki, Sophia .
BREAST CANCER RESEARCH, 2011, 13 (03)
[10]   The basics of epithelial-mesenchymal transition [J].
Kalluri, Raghu ;
Weinberg, Robert A. .
JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (06) :1420-1428